从防御到疾病:IFITM3在免疫和阿尔茨海默病中的作用
Zoe Kehs1, Abigail C Cross2, Yue-Ming Li1
1Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Programs of Pharmacology, Weill Graduate School of Medical Sciences of Cornell University, New York, NY, USA.
概括
干扰素诱导的跨膜蛋白3 (IFITM3) 在免疫和阿尔茨海默病 (AD) 风险方面发挥作用. 防止IFITM3上调可能为AD提供新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 干扰素诱导的跨膜蛋白3 (IFITM3) 是一种天生的免疫蛋白.
- IFITM3是一种由各种干扰素上调调节的干扰素刺激基因 (ISG).
- 它的表达与病毒感染,阿尔茨海默氏症 (AD) 和癌症有关.
研究的目的:
- 探索IFITM3.3的多方面的作用.
- 研究IFITM3在先天性免疫和病毒病原性中的功能.
- 检查IFITM3在阿尔茨海默氏症病原发生中的参与及其作为治疗点的潜力.
主要方法:
- 分析IFITM3在病毒融合和内体逃生中的功能.
- 调查IFITM3作为γ-分泌酶调节蛋白的作用.
- 检查影响IFITM3表达的因素及其与粉样β (Aβ) 生产的联系.
主要成果:
- IFITM3 干扰病毒的进入,并防止病毒从内分泌体逃逸.
- IFITM3调节了粉样蛋白前体蛋白 (APP) 和Notch1裂变的处理.
- 由于衰老,炎症或感染导致的IFITM3表达的增加,会增加γ-分泌酶活性和Aβ的产生,从而增加AD风险.
结论:
- IFITM3是先天免疫的关键蛋白质,其影响超出病毒防御范围.
- IFITM3在调节APP处理和Aβ生产中的作用突显了其在AD中的重要性.
- 针对IFITM3的上调,为新型阿尔茨海默病治疗提供了一个有希望的途径.
相关概念视频
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
01:23Role of Neurotransmitters in Memory
2.8K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.8K
01:29Alzheimer Disease l: Introduction
20
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
20
01:23Alzheimer Disease ll: Pathophysiology
32
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
32
01:25Inflammatory Bowel Disease III: Crohn's Disease
29
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
29